Intestinal metabolism of cyclosporine A in human heart transplant recipients

被引:3
|
作者
Lehle, K
Kirchner, G
Sewing, KF
Rupprecht, L
Merk, J
Preuner, JG
机构
[1] Univ Regensburg, Klinikum, Clin Cardiothorac Surg, D-93042 Regensburg, Germany
[2] Med Hsch Hannover, Inst Allgemeine Pharmakol, Hannover, Germany
关键词
D O I
10.1016/S0041-1345(98)01332-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:4044 / 4044
页数:1
相关论文
共 50 条
  • [41] Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients
    Schweiger, Martin
    Wasler, Andre
    Prenner, Guenther
    Stiegler, Philipp
    Stadlbauer, Vanessa
    Schwarz, Michaela
    Tscheliessnigg, Karlheinz
    TRANSPLANT IMMUNOLOGY, 2006, 16 (01) : 46 - 51
  • [42] THE MANAGEMENT OF HEART-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE IN IRELAND - MONITORING OF CYCLOSPORINE CONCENTRATIONS IN BLOOD
    KYNE, F
    MAGUIRE, S
    UACONAILL, D
    OBROIN, S
    CLARKE, E
    MCCANN, S
    DERVAN, P
    WOOD, AE
    IRISH JOURNAL OF MEDICAL SCIENCE, 1990, 159 (9-12) : 272 - 274
  • [43] Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients
    Lehmkuhl, Hans B.
    Arizon, Jose
    Vigano, Mario
    Almenar, Luis
    Gerosa, Gino
    Maccherini, Massimo
    Varnous, Shaida
    Musumeci, Francesco
    Hexham, J. Mark
    Mange, Kevin C.
    Livi, Ugolino
    TRANSPLANTATION, 2009, 88 (01) : 115 - 122
  • [44] A PHARMACOKINETIC COMPARISON OF CYCLOSPORINE ORAL SOLUTION AND CYCLOSPORINE CAPSULES IN HEART AND LUNG-TRANSPLANT RECIPIENTS
    EADON, H
    ROSE, M
    ONEILL, R
    LEAVER, N
    YACOUB, M
    TRANSPLANT INTERNATIONAL, 1995, 8 (01) : 35 - 40
  • [45] Lipid metabolism and immunosuppressive therapy in heart transplant recipients
    Berman, M
    Ben-Gal, T
    Stamler, A
    Kogan, A
    Shapira, Y
    Sagie, A
    Saute, M
    Kramer, M
    Aravot, D
    Vidne, B
    Sahar, G
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 677 - 677
  • [46] Lipid metabolism alteration and treatment in heart transplant recipients
    DeLorgeril, M
    LATE GRAFT LOSS, 1997, 28 : 151 - 160
  • [47] Energy metabolism in diabetic and nondiabetic heart transplant recipients
    Benedini, S
    Gamba, A
    Fiocchi, R
    Mammana, C
    Battezzati, A
    Del Maschio, A
    Scifo, P
    Perseghin, G
    Sereni, LP
    Luzi, L
    DIABETES CARE, 2002, 25 (03) : 530 - 536
  • [48] EFFECTS OF CYCLOSPORINE ON GLUCOSE-METABOLISM IN KIDNEY-TRANSPLANT RECIPIENTS AND RATS
    YAGISAWA, T
    TAKAHASHI, K
    TERAOKA, S
    TOMA, H
    AGISHI, T
    OTA, K
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1801 - 1803
  • [49] Characteristics of human calicivirus enteritis in intestinal transplant recipients
    Kaufman, SS
    Chatterjee, TK
    Fuschino, TE
    Morse, DL
    Morotti, RA
    Magid, MS
    Gondolesi, GE
    Florman, SS
    Fishbein, TM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 40 (03): : 328 - 333
  • [50] A randomized controlled triple of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients
    Chan, C
    Maurer, J
    Cardella, C
    Cattran, D
    Pei, Y
    TRANSPLANTATION, 1997, 63 (10) : 1435 - 1440